http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-2013526-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00
filingDate 2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a09e783a8030514579ebd786794976ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b38ca19f21f151b0cda9bc85650d81b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96af9e64ddf2e70ccd30cff042edb0d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_399943b52768cda211ace3c8cb61e21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba6f86a3ce9c165d0784ed0a85ff0c72
publicationDate 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-2013526-A3
titleOfInvention Salts of abiraterone acetate
abstract The present invention relates to salts of abiraterone acetate of the formula I, in crystalline or amorphous form, to a process for the preparation of salts of abiraterone acetate, to their use in the preparation of a pharmaceutical composition, and to the use of such salts for the preparation of abiraterone acetate in the form of the free base or any other pharmaceutical salt of abiraterone acetate .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113061154-A
priorityDate 2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12358731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425013245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9821849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101

Total number of triples: 42.